Embryology and genetics of the mammalian gonads and ducts

Knobil and Neill's Physiology of Reproduction

Volumn , Issue , 2006, Pages 313-336

  Parker, Keith L ^a   Schimmer, Bernard P ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b CH Best Institute   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33947262111     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012515400-0/50013-0     Document Type: Chapter

References (213)

1. Swain A., Lovell-Badge R. Mammalian sex determination: a molecular drama. Genes Dev. 1999, 13:755-766.
2. Jost A., Vigier B., Prepin J., Perchellet J.P. Studies on sex differentiation in mammals. Rec. Prog. Horm. Res. 1973, 29:1-35.
3. MacLaughlin D.T., Donahoe P.K. Sex determination and differentiation. N. Engl. J. Med. 2004, 350:367-378.
4. Byskov A.G., Hoyer P.E. Embryology of mammalian gonads and ducts. The Physiology of Reproduction 1994, Raven Press, San Diego. E. Knobil, J. Neill (Eds.).
5. Staack A., Donjacour A.A., Brody J., Cunha G.R., Carroll P. Mouse urogenital development: a practical approach. Differentiation 2003, 71:402-413.
6. Cupp A.S., Skinner M.K. Embryonic Sertoli cell differentiation. Sertoli Cell Biology 2004, 43-70. Elsevier Science, New York. M.K. Skinner, M.D. Griswold (Eds.).
7. McLaren A. Primordial germ cells in the mouse. Dev. Biol. 2003, 262:1-15.
8. Molyneaux K., Wylie C. Primordial germ cell migration. Int. J. Dev. Biol. 2004, 48:537-544.
9. Russell D.W., Wilson J.D. Steroid 5 alpha-reductase: two genes/two enzymes. Annu. Rev. Biochem. 1994, 63:25-61.
10. Hanley N.A., Hagan D.M., Clement-Jones M., et al. SRY, SOX9, and DAX1 expression patterns during human sex determination and gonadal development. Mech. Dev. 2000, 91:403-407.
11. de Santa Barbara P., Moniot B., Poulat F., Berta P. Expression and subcellular localization of SF-1, SOX9, WT1, and AMH proteins during early human testicular development. Dev Dyn. 2000, 217:293-298.
12. Hacker A., Capel B., Goodfellow P., Lovell-Badge R. Expression of Sry, the mouse sex determining gene. Development 1995, 121:1603-1614.
13. Albrect K., Eicher E. Evidence that Sry is expressed in pre-Sertoli cells and Sertoli and granulosa cells have a common precursor. Dev. Biol. 2001, 240:92-107.
14. Brennan J., Capel B. One tissue, two fates: molecular genetic events that underlie testis versus ovary development. Nat. Rev. Genet. 2004, 5:509-521.
15. Clarkson M.J., Harley V.R. Sex with two SOX on: SRY and SOX9 in testis development. Trends Endocrinol. Metab. 2002, 13:106-1011.
16. Koopman P., Bullejos M., Bowles J. Regulation of male sexual development by Sry and Sox9. J. Exp. Zool. 2001, 290:463-474.
17. Vidal V.P., Chaboissier M.C., de Rooij D.G., Schedl A. Sox9 induces testis development in XX transgenic mice. Nat. Genet. 2001, 28:216-217.
18. McLaren A. Somatic and germ cell sex in mammals. Philos. Trans. R. Soc. Lond. 1988, 322:3-9.
19. Ikeda Y., Shen W.H., Ingraham H.A., Parker K.L. Development expression of mouse steroidogenic factor-1, an essential regulator of the steroid hydroxylases. Mol. Endocrinol. 1994, 8:654-662.
20. Wagner K.D., Wagner N., Schedl A. The complex life of WT1. J. Cell Sci. 2003, 116:1653-1658.
21. Dome J.S., Coppes M.J. Recent advances in Wilms tumor genetics. Curr. Opin. Pediatr. 2002, 14:5-11.
22. Call K.M., Glaser T., Ito C.Y., et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 1990, 60:509-520.
23. Gessler M., Poustka A., Cavenee W., Neve R.L., Orkin S.H., Bruns G.A. Homozygous deletion in Wilms tumors of a zinc-finger gene identified by chromosomal jumping. Nature 1990, 343:774-778.
24. Discenza M.T., Pelletier J. Insights into the physiological role of WT1 from studies of genetically modified mice. Physiol. Genomics. 2004, 16:287-300.
25. Pelletier J., Schalling M., Buckler A.J., Rogers A., Haber D.A., Housman D. Expression of the Wilms' tumor gene WT1 in the murine urogenital system. Genes Dev. 1991, 5:1345-1356.
26. Rackley R.R., Flenniken A.M., Kuriyan N.P., Kessler P.M., Stoler M.H., Williams B.R. Expression of the Wilms' tumor suppressor gene WT1 during mouse embryogenesis. Cell Growth Differ. 1993, 4:1023-1031.
27. Armstrong J.F., Pritchard-Jones K., Bickmore W.A., Hastie N.D., Bard J.B. The expression of Wilms' tumour gene, WT1, in the developing mammalian embryos. Mech. Dev. 1993, 40:85-97.
28. Hanley N.A., Ball S.G., Clement-Jones M., Hagan D.M., Strachan T., Lindsay S., Robson S., Ostrer H., Parker K.L., Wilson D.I. Expression of steroidogenic factor 1 and Wilms' tumour 1 during early human gonadal development and sex determination. Mech. Dev. 1999, 87:175-178.
29. Pelletier J., Bruening W., Kashtan C.E., et al. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 1991, 67:437-447.
30. Barbaux S., Niaudet P., Gubler M.C., et al. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat. Genet. 1997, 17:467-470.
31. Kikuchi H., Takata A., Akasaka Y., et al. Do intronic mutations affecting splicing of WT1 exon 9 cause Frasier syndrome?. J. Med. Genet. 1998, 7:45-48.
32. Klamt B., Koziell A., Poulat F., Wieacker P., Scambler P., Berta P., Gessler M. Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/KTS splice isoforms. Hum. Mol. Genet. 1998, 7:709-714.
33. Kreidberg J.A., Sariola H., Loring J.M., Maeda M., Pelletier J., Housman D., Jaenisch R. WT1 is required for early kidney development. Cell 1993, 74:679-691.
34. Hammes A., Guo J.K., Lutsch G., Leheste J.R., Landrock D., Ziegler U., Gubler M.C., Schedl A. Two splice variants of the Wilm's tumor 1 gene distinct functions during sex determination and nephron formation. Cell 2001, 106:319-329.
35. Hossain A., Saunders G.F. The human sex-determining gene SRY is a direct target of WT1. J. Biol. Chem. 2001, 276:16817-16823.
36. Matsuzawa-Watanabe Y., Inoue J., Semba K. Transcriptional activity of testis-determining factor SRY is modulated by the Wilms' tumor 1 gene product, WT1. Oncogene. 2003, 22:7900-7904.
37. Wilhelm D., Englert C. The Wilms tumor suppressor WT1 regulates early gonad development by activation of Sf1. Genes Dev. 2002, 16:1839-1851.
38. Kim J., Prawitt D., Bardeesy N., Torban E., Vicaner C., Goodyer P., Zabel B., Pelletier J. The Wilms' tumor suppressor gene (wt1) product regulates Dax-1 gene expression during gonadal differentiation. Mol. Cell. Biol. 1999, 19:2289-2299.
39. Sim E.U., Smith A., Szilagi E., Rae F., Ioannou P., Lindsay M.H., Little M.H. Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1. Oncogene. 2002, 21:2948-2960.
40. Nachtigal M.W., Hirokawa Y., Enyeart-VanHouten D.L., Flanagan J.N., Hammer G.D., Ingraham H.A. Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF1 in sex-specific gene expression. Cell 1998, 93:445-454.
41. Du X., Hublitz P., Gunther T., Wilhelm D., Englert C., Schule R. The LIM-only coactivator FHL2 modulates WT1 transcriptional activity during gonadal differentiation. Biochim. Biophys. Acta. 2002, 1577:93-101.
42. Val P., Lefrancois-Martinez A.M., Veyssiere G., Martinez A. SF-1 a key player in the development and differentiation of steroidogenic tissues. Nucl. Recept. 2003, 1:1-23.
43. Parker K.L., Schimmer B.P. Steroidogenic factor 1: a key determinant of endocrine development and function. Endocrine Rev. 1997, 18:361-377.
44. Lala D.S., Rice D.A., Parker K.L. Steroidogenic factor I, a key regulator of steroidogenic enzyme expression, is the mouse homolog of fushi tarazu-factor I. Mol. Endocrinol. 1992, 6:1249-1258.
45. Honda S-I., Morohashi K-I., Nomura M., Takeya H., Kitajima M., Omura T. Ad4BP regulating steroidogenic P-450 gene is a member of steroid hormone receptor superfamily. J. Biol. Chem. 1993, 268:7494-7502.
46. Shen W-H., Moore C.C.D., Ikeda Y., Parker K.L., Ingraham H.A. Nuclear receptor steroidogenic factor 1 regulates MIS gene expression: a link to the sex determination cascade. Cell 1994, 77:651-661.
47. Giuili G., Shen W.H., Ingraham H.A. The nuclear receptor SF-1 mediates sexually dimorphic expression of Müllerian Inhibiting Substance, in vivo. Development 1997, 124:1799-1807.
48. Arango N., Lovell-Badge R., Behringer R.R. Targeted mutagenesis of the endogenous mouse Mis gene promoter: in vivo definition of genetic pathways of vertebrate sexual development. Cell 1999, 99:409-419.
49. De Santa Barbara P., Bonneaud N., Boizet B., Desclozeaux M., Moniot B., Sudbeck P., Scherer G., Poulat F., Berta P. Direct interaction of SRY-related protein SOX9 and steroidogenic factor 1 regulates transcription of the human anti-Müllerian hormone gene. Mol. Cell. Biol. 1998, 18:6653-6665.
50. Hatano O., Takayama K., Imai T., et al. Sex-dependent expression of a transcription factor, Ad4BP, regulating steroidogenic P-450 genes in the gonads during prenatal and postnatal rat development. Development 1995, 120:2787-2797.
51. Luo X., Ikeda Y., Parker K.L. A cell-specific nuclear receptor is essential for adrenal and gonadal development and for male sexual differentiation. Cell 1994, 77:481-490.
52. Sadovsky Y., Crawford P.A., Woodson K.G., et al. Mice deficient in the orphan receptor steroidogenic factor 1 lack adrenal glands and gonads but express P450 side-chain-cleavage enzyme in the placenta and have normal embryonic serum levels of corticosteroids. Proc. Natl. Acad. Sci. U S A 1995, 92:10939-10943.
53. Achermann J.C., Ito M., Ito M., Hindmarsh P.C., Jameson J.L. A mutation in the gene encoding steroidogenic factor 1 causes XY sex reversal and adrenal failure in humans. Nat. Genet. 1999, 22:125-126.
54. Biason-Lauber A., Schoenle E.J. Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF1) and adrenocortical insufficiency. Am. J. Hum. Genet. 2000, 67:1563-1568.
55. Achermann J.C., Ozisik G., Ito M., Orun U.A., Harmancik K., Gurakan B., Jameson J.L. Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner. J. Clin. Endocrinol. Metab. 2002, 87:1829-1833.
56. Correa R.V., Domenice S., Bingham N.R., Billerbeck E.C., Rainey W.E., Parker K.L., Mendonca B. A microdeletion in the ligand binding domain of human steroidogenic factor 1 causes XY sex reversal without adrenal insufficiency. J. Clin. Endocrinol. Metab. 2004, 89:1767-1772.
57. Mallet D., Bretones P., Michel-Calemard L., Dijoud F., David M., Morel Y. Dysgenesis without adrenal insufficiency in a 46, XY patient heterozygous for the nonsense C16X mutation: a case of SF1 haploinsufficiency. J. Clin. Endocrinol. Metab. 2004, 89:4829-4832.
58. Shawlot W., Behringer R.R. Requirement for Lim1 in head-organizer function. Nature 1995, 374:425-430.
59. Birk O.S., Casiano D.E., Wassif C.A., et al. The LIM homeobox gene Lhx9 is essential for mouse gonad formation. Nature 2000, 403:909-912.
60. Miyamoto N., Yoshida M., Kuratani S., Matsuo I., Aizawa S. Defects of urogenital development in mice lacking Emx2. Development 1997, 124:1653-1664.
61. Cecchi C., Boncinelli E. Emx homeogenes and mouse brain development. Trends Neurosci. 2000, 23:347-352.
62. Sinclair A.H., Berta P., Palmer M.S., et al. A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 1990, 346:240-244.
63. Berta P., Hawkins J.R., Sinclair A.H., et al. Genetic evidence equating SRY and the testis-determining factor. Nature 1990, 348:448-450.
64. Jager R.J., Anvret M., Hall K., Scherer G. A human XY female with a frame shift mutation in the candidate tesis-determining gene SRY. Nature 1990, 348:452-454.
65. Koopman P., Gubbay J., Vivian N., Goodfellow P., Lovell-Badge R. Male development of chromosomally female mice transgenic for Sry. Nature 1991, 351:117-121.
66. Pevny L.H., Lovell-Badge R. Sox genes find their feet. Curr. Opin. Genet. Dev. 1997, 7:338-344.
67. Cameron F.J., Sinclair A.H. Mutations in SRY and SOX9: testis determining genes. Hum. Mutat. 1997, 9:388-395.
68. Harley V.R., Layfield S., Mitchell C.L., et al. Defective importin beta recognition and nuclear import of the sex-determining factor SRY are associated with XY sex-reversing mutations. Proc. Natl. Acad. Sci. U S A 2003, 100:7045-7050.
69. Werner M.H., Huth J.R., Gronenborn A.M., Clore G.M. Molecular basis of human 46, XY sex reversal revealed from the three-dimensional solution structure of the human SRY-DNA complex. Cell 1995, 81:705-714.
70. Pontiggia A., Rimini R., Harley V.R., Goodfellow P.N., Lovell-Badge R., Bianchi M.E. Sex reversing mutations affecting the architecture of SRY-DNA complexes. EMBO J. 1994, 13:6115-6124.
71. Thomas J.O., Travers A.A. HMG1 and 2, and related 'architectural' DNA-binding proteins. Trends Biochem. Sci. 2001, 26:167-174.
72. Harley V.R., Clarkson M.J., Argentaro A. The molecular action and regulation of the testis-determining factors, SRY (sex-determining region on the Y chromosome) and SOX9 [SRY-related high-mobility group (HMG) box 9]. Endocr. Rev. 2003, 24:466-487.
73. Canning C.A., Lovell-Badge R. Sry and sex determination: how lazy can it be?. Trends Genet. 2002, 18:111-113.
74. Hiramatsu R., Kanai Y., Mizukami T., et al. Regionally distinct potencies of mouse XY genital ridge to initiate testis differentiation dependent on anteroposterior axis. Dev. Dyn. 2003, 228:247-253.
75. Foster J.W., Dominguez-Steglich M.A., Guioli S., et al. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 1994, 372:525-530.
76. Wagner T., Wirth J., Meyer J., et al. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 1994, 79:1111-1120.
77. Kent J., Wheatley S.C., Andrews J.E., Sinclair A.H., Koopman P. A male-specific role for SOX9 in vertebrate sex determination. Development 1996, 122:2813-2822.
78. Morais da Silva S., Hacker A., Harley V., Goodfellow P., Swain A., Lovell-Badge R. Sox9 expression during gonadal development implies a conserved role for the gene in testis determination in mammals and birds. Nat. Genet. 1996, 14:62-68.
79. Bernard P., Tang P., Liu S., Dewing P., Harley V.R., Vilain E. Dimerization of SOX9 is required for chondrogenesis, but not for sex determination. Hum. Mol. Genet. 2003, 12:1755-1765.
80. Sock E., Pagon R.A., Keymolen K., Lissens W., Wegner M., Scherer G. Loss of DNA-dependent dimerization of the transcription factor SOX9 as a cause for campomelic dysplasia. Hum. Mol. Genet. 2003, 12:1439-1447.
81. Shen J.H., Ingraham H.A. Regulation of the orphan nuclear receptor steroidogenic factor 1 by Sox proteins. Mol. Endocrinol. 2002, 16:529-540.
82. Schepers G., Wilson M., Wilhelm D., Koopman P. SOX8 is expressed during testis differentiation in mice and synergizes with SF-1 to activate the Amh promoter in vitro. J. Biol. Chem. 2003, 278:28101-28108.
83. Chaboissier M.C., Kobayashi A., Vidal V.I., Lutzkendorf S., van de Kant H.J., Wegner M., de Rooij D.G., Behringer R.R., Schedl A. Functional analysis of Sox8 and Sox9 during sex determination in the mouse. Development 2004, 131:1891-1990.
84. Huang B., Wang S., Ning Y., Lamb A.N., Bartley J. Autosomal sex reversal caused by duplication of SOX9. Am. J. Med. Genet. 1999, 87:349-353.
85. Bishop C.E., Whitworth D.J., Qin Y., et al. A transgenic insertion upstream of sox9 is associated with dominant XX sex reversal in the mouse. Nat. Genet. 2000, 26:490-494.
86. Qin Y., Kong L.K., Poirier C., Truong C., Overbeek P.A., Bishop C.E. Long-range activation of Sox9 in Odd Sex (Ods) mice. Hum. Mol. Genet. 2004, 13:1213-1218.
87. Vidal V.P., Chaboissier M.C., de Rooij D.G., Schedl A. Sox9 induces testis development in XX transgenic mice. Nat. Genet. 2001, 28:216-217.
88. Viger R.S., Mertineit C., Trasler J.M., Nemer M. Transcription factor GATA-4 is expressed in a sexually dimorphic pattern during mouse gonadal development and is a potent activator of the Müllerian inhibiting substance promoter. Development 1998, 125:2665-2675.
89. Tremblay J.J., Viger R.S. GATA factors differentially activate multiple gonadal promoters through conserved GATA regulatory elements. Endocrinology 2001, 142:977-986.
90. Tremblay J.J., Viger R.S. Nuclear receptor Dax-1 represses the transcriptional cooperation between GATA-4 and SF-1 in Sertoli cells. Biol. Reprod. 2001, 64:1191-1199.
91. Tevosian S.G., Albrecht K.H., Crispino J.D., Fujiwara Y., Eicher E.M., Orkin S.H. Gonadal differentiation, sex determination and normal Sry expression in mice require direct interaction between transcription partners GATA4 and FOG2. Development 2002, 129:4627-4634.
92. Raymond C.S., Shamu C.E., Shen M.M., Seifert K.J., Hirsch B., Hodgkin J., Zarkower D. Evidence for evolutionary conservation of sex-determining genes. Nature 1998, 391:691-695.
93. Raymond C.S., Shamu C.E., Shen M.M., Seifert K.J., Hirsch B., Hodgkin J., Zarkower D. Expression of Dmrt1 in the genital ridge of mouse and chicken embryos suggests a role in vertebrate sexual development. Dev. Biol. 1999, 215:208-220.
94. Raymond, C. S., Murphy, M. W., O'Sullivan, M. G., Bardwell, V. J., and Zarkower, D. Dmrt1, a gene related to worm and fly sexual regulators, is required for mammalian testis differentiation. Genes Dev. 14, 2587-2595.
95. Katoh-Fukui Y., Tsuchiya R., Shiroishi T., Nakahara Y., Hashimoto N., Noguchi K., Higashinakagawa T. Male to female sex reversal in M33 mutant mice. Nature 1998, 393:688-692.
96. Zanaria E., Muscatelli F., Bardoni B., et al. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenital. Nature 1994, 372:635-641.
97. Zazopoulos E., Lalli E., Stocco D.M., Sassone-Corsi P. DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis. Nature 1997, 390:311-315.
98. Lalli E., Ohe K., Hindelang C., Sassone-Corsi P. Orphan receptor DAX-1 is a shuttling RNA binding protein associated with polyribosomes via mRNA. Mol. Cell Biol. 2000, 20:4910-4921.
99. Iyer A.K., McCabe E.R. Molecular mechanisms of DAX1 action. Mol. Genet. Metab. 2004, 83:60-73.
100. Ito M., Yu R., Jameson J.L. DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita. Mol. Cell. Biol. 1997, 17:1476-1483.
101. Crawford P.A., Dorn C., Sadovsky Y., Milbrandt J. Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-CoR to steroidogenic factor 1. Mol. Cell. Biol. 1998, 18:2949-2956.
102. Nachtigal M.W., Hirokawa Y., Enyeart-VanHouten D.L., Flanagan J.N., Hammer G.D., Ingraham H.A. Wilms' tumor 1 and DAX-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression. Cell 1998, 93:445-454.
103. Muscatelli F., Strom T.M., Walker A.P., et al. Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotrophic hypogonadism. Nature 1994, 372:672-676.
104. Achermann J.C., Meeks J.J., Jameson J.L. Phenotypic spectrum of mutations in DAX-1 and SF-1. Mol. Cell. Endocrinol. 2001, 185:17-25.
105. Bardoni B., Zanaria E., Guioli S., et al. A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal. Nat. Genet. 1994, 7:497-501.
106. Swain A., Narvaez S., Burgoyne P., Camerino G., Lovell-Badge R. Dax1 antagonizes Sry action in mammalian sex determination. Nature 1998, 391:761-767.
107. Yu R.N., Ito M., Saunders T.L., Camper S.A., Jameson J.L. Role of AhCh in gonadal development and gametogenesis. Nat. Genet. 1998, 20:353-357.
108. Meeks J.J., Weiss J., Jameson J.L. Dax1 is required for testis determination. Nat. Genet. 2003, 34:32-33.
109. Meeks J.J., Crawford S.E., Russell T.A., Morohashi K., Weiss J., Jameson J.L. Dax1 regulates testis cord organization during gonadal differentiation. Development 2003, 30:1029-1036.
110. Bottcher R.T., Niehrs C. Fibroblast growth factor signalling during early vertebrate development. Endocr. Rev. 2005, 26:63-77.
111. Colvin J.S., Green R.P., Schmahl J., Capel B., Ornitz D.M. Male-to-female sex reversal in mice lacking fibroblast growth factor 9. Cell 2001, 104:875-889.
112. Schmahl J., Kim Y., Colvin J.S., Ornitz D.M., Capel B. Fgf9 induces proliferation and nuclear localization of FGFR2 in Sertoli precursors during male sex differentiation. Development 2004, 131:3627-3636.
113. Betsholtz C., Karlsson L., Lindahlm P. Developmental roles of platelet-derived growth factors. Bioessays 2001, 23:494-507.
114. Brennan J., Tilmann C., Capel B. Pdgfralpha mediates testis cord organization and fetal Leydig cell development in the XY gonad. Genes Dev. 2003, 17:800-810.
115. Nef S., Verma-Kurvari S., Merenmies J., Vassalli J.D., Efstratiadis A., Accili D., Parada L. Testis determination requires insulin receptor family function in mice. Nature 2003, 426:291-295.
116. Ingham P.W., McMahon A.P. Hedgehog signaling in animal development: paradigms and principles. Genes Dev. 2001, 15:3059-3087.
117. Jeong J., McMahon A.P. Cholesterol modification of Hedgehog family proteins. J. Clin. Invest. 2002, 110:591-596.
118. Neri G., Opitz J. Syndromal (and nonsyndromal) forms of male pseudohermaphroditism. Am. J. Med. Genet. 1999, 89:201-209.
119. Yao H.H., Capel B. Disruption of testis cords by cyclopamine or forskolin reveals independent cellular pathways in testis organogenesis. Dev. Biol. 2002, 246:356-365.
120. Clark A., Garland K., Russell L. Desert Hedgehog (Dhh) gene is required in the mouse testis for formation of adult-type Leydig cells and normal development of peritubular cells and seminiferous tubules. Biol. Reprod. 2000, 63:1825-1838.
121. Yao H.H., Whoriskey W., Capel B. Desert hedgehog/Patched 1 signaling specifies fetal Leydig cell fate in testis organogenesis. Genes Dev. 2002, 16:1433-1440.
122. Umehara F., Tate G., Itoh K., Yamaguchi N., Douchi T., Mitsuya T., Osame M. A novel mutation of desert hedgehog in a patient with 46, XY partial gonadal dysgenesis accompanied by minifascicular neuropathy. Am. J. Hum. Genet. 2000, 67:1302-1305.
123. Canto P., Soderlund D., Reyes E., Mendez J.P. Mutations in the desert hedgehog (DHH) gene in patients with 46,XY complete pure gonadal dysgenesis. J. Clin. Endocrinol. Metab. 2004, 89:4480-4483.
124. Parmantier E., Lynn B., Lawson D., Turmaine M., Namini S.S., Chakrabarti L., McMahon A.P., Jessen K.R., Mirsky R. Schwann cell-derived Desert hedgehog controls the development of peripheral nerve sheaths. Neuron. 1999, 23:713-724.
125. Bitgood M.J., Shen L., McMahon A.P. Sertoli cell signaling by Desert hedgehog regulates the male germline. Curr. Biol. 1996, 6:298-304.
126. Kitamura K., Yanazawa M., Sugiyama N., Miura H., Iizuka-Kogo A., Kusaka M., Omichi K., Suzuki R., Kata-Fukui Y., Kamiirisa K., Kamijo S., et al. Mutation of ARX causes abnormal development of forebrain and testes and X-linked lissencephaly with abnormal genitalia in humans. Nat. Genet. 2001, 32:359-369.
127. Sherr E.H. The ARX story (epilepsy, mental retardation, autism, and cerebral malformations): one gene leads to many phenotypes. Curr. Opin. Pediatr. 2003, 15:567-577.
128. Cui S., Ross A., Stallings N., Parker K.L., Capel B., Quaggin S.E. Disrupted gonadogenesis and maleto-female sex reversal in Pod1 knockout mice. Development 2004, 131:4095-4105.
129. Swain A., Zanaria E., Hacker A., Lovell-Badge R., Camerino G. Mouse Dax1 expression is consistent with a role in sex determination as well as in adrenal and hypothalamus function. Nat Genet. 1996, 12:404-409.
130. Nelson W.J., Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 2004, 303:1483-1487.
131. Malbon C.C. Frizzleds: new members of the superfamily of G-protein-coupled receptors. Front. Biosci. 2004, 9:1048-1058.
132. Vainio S., Heikkala M., Kispert A., Chin N., McMahon A.P. Female development in mammals is regulated by Wnt4 signaling. Nature 1999, 397:405-409.
133. Yao H.H.C., Matzuk M.M., Jorgez C.J., Menke D.B., Page D.C., Swain A., Capel B. Follistatin operates downstream of Wnt4 in mammalian ovary organogenesis. Dev. Dyn. 2004, 230:210-215.
134. Jordan B.K., Mohammed M., Ching S.T., Delot E., Chen X.N., Dewing P., Swain A., Rao P.N., Elejaide B.R., Vilain E. Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans. Am. J. Hum. Genet. 2001, 68:1102-1109.
135. Biason-Lauber A., Konrad D., Navratil F., Schoenle E.J. A WNT4 mutation associated with Müllerian-duct regression and virilization in a 46,XX woman. N. Engl. J. Med. 2004, 351:792-798.
136. Jeays-Ward K., Hoyle C., Brennan J., Dandonneau M., Alldus G., Capel B., Swain A. Endothelial and steroidogenic cell migration are regulated by WNT4 in the developing mammalian gonad. Development 2003, 130:3663-3670.
137. Menke D.B., Page D.C. Sexually dimorphic gene expression in the developing mouse gonad. Gene Expr. Patterns. 2002, 2:359-366.
138. Yao H.H., Matzuk M.M., Jorgez C.J., Menke D.B., Page D.C., Swain A., Capel B. Follistatin operates downstream of Wnt4 in mammalian ovary organogenesis. Dev. Dyn. 2004, 230:210-215.
139. Mizusaki H., Kawabe K., Mukai T., Ariyoshi E., Kasahara M., Yoshioka H., Swain A., Morohashi K. Dax-1 (dosage-sensitive sex reversal-adrenal hypoplasia congenita critical region on the X chromosome, gene 1) gene transcription is regulated by wnt4 in the female developing gonad. Mol. Endocrinol. 2003, 17:507-519.
140. Matzuk M.M., Burns K., Viveiros M.M., Eppig J. Intracellular communication in the ovary: oocytes carry the conversation. Science 2002, 296:2178-2180.
141. Soyal S.M., Amleh A., Dean J. FIGalpha, a germ cell-specific transcription factor required for ovarian follicle formation. Development 2000, 127:4645-4654.
142. Shimasaki S., Moore R.K., Otsuka F., Erickson G.F. The bone morphogenetic protein system in mammalian reproduction. Endocr. Rev. 2004, 25:72-101.
143. Crisponi L., Deiana M., Loi A., Chiappe F., Uda M., Amati P., Bisceglia L., Zelante L., Nagaraja R., Porcu S., Ristaldi M.S., Marzella R., Rocchi M., Nicolino M., Lienhardt-Roussie A., Nivelon A., Verloes A., Schlessinger D., Gasparini P., Bonneau D., Cao A., Pilia G. The putative forkhead transcription factor FOXL2 is mutated in Blepharophimosis/ptosis/epicanthus inversus syndrome. Nat. Genet. 2001, 27:159-166.
144. Uda M., Ottolenghi C., Crisponi L., Garcia J.E., Deina M., Kimber W., Forabosco A., Cao A., Schlessinger D., Pilia G. Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development. Hum. Mol. Genet. 2004, 13:1171-1181.
145. Schmidt D., Ovitt C.E., Anlag K., Fehsenfeld S., Gredsted L., Treier A.C., Treier M. The murine wingedhelix transcription factor Fox12 is required for granulosa cell differentiation and ovary maintenance. Development 2004, 131:933-942.
146. McClaren A. Primordial germ cells in the mouse. Dev. Biol. 2003, 262:1-15.
147. Molyneaux K., Wylie C. Primordial germ cell migration. Int. J. Dev. Biol. 2004, 48:537-544.
148. Lawson K.A., Hage W.J. Clonal analysis of the origin of primordial germ cells in the mouse. Ciba Found. Symp. 1994, 182:68-91.
149. Lawson K.A., Dunn R.R., Roelen B.A., Zeinstra L.M., Davis A.M., Wright C.V., Korving J.P., Hogan B.L. Bmp4 is required for the generation of primordial germ cells in the mouse embryo. Genes Dev. 1999, 13:424-436.
150. Ying Y., Liu X.M., Marble A., Lawson K.A., Zhao G.O. Requirement of Bmp8b for the generation of primordial germ cells in the mouse. Mol. Endocrinol. 2000, 14:1053-1063.
151. Ying Y., Qi X., Zhao G-Q. Induction of primordial germ cells from murine epiblasts by synergistic action of Bmp4 and Bmp8b signaling pathways. Proc. Natl. Acad. Sci. U S A 2001, 98:7858-7862.
152. Tanaka S.S., Matsui Y. Developmentally regulated expression of mil-1 and mil-2, mouse interferon-induced transmembrane protein like genes, during formation and differentiation of primordial germ cells. Gene Expr. Patterns 2002, 2:297-303.
153. Saitou M., Barton S.C., Surani M.A. A molecular program for the specification of germ cell fate in mice. Nature 2002, 418:293-300.
154. Bortvin A., Goodheart M., Liao M., Page D.C. Dppa3/Pgc7/stella is a maternal factor but is not required for germ cell specification in mice. BMC Dev. Biol. 2004, 23:2.
155. Forbes A., Lehmann R. Nanos and pumilio have critical roles in the development and function of Drosophila germline stem cells. Development 1998, 125:679-690.
156. Tsuda M., Sasaoka Y., Kiso M., Abe K., Haraguchi S., Kobayashi S., Saga Y. Conserved role of nanos proteins in germ cell development. Science 2003, 301:1239-1241.
157. Wylie C. Germ cells. Cell 1999, 96:165-174.
158. Scholer H.R., Hatzopoulos A.K., Balling R., Suzuki N., Gruss P. A family of octamer-specific proteins present during mouse embryogenesis: evidence for germline-specific expression of an Oct factor. EMBO J. 1989, 8:2543-2550.
159. Ara T., Nakamura Y., Egawa T., Sugiyama T., Abe K., Kishimoto T., Matsui Y., Nagasawa T. Impaired colonization of the gonads by primordial germ cells in mice lacking a chemokine, stromal cell-derived factor-1 (SDF-1). Proc. Natl. Acad. Sci. U S A 2003, 100:5319-5323.
160. Molyneaux K., Zinszner H., Kunwar P., Schaible K., Stebler J., Sunshine M., O'Brien W., Raz E., Littman D., Wylie C. The chemokine SDF1/CXCL12 and its receptor CXCR4 regulate mouse germ cell migration and survival. Development 2003, 130:4279-4286.
161. Hunter R.H.F. Sex Determination, Differentiation and Intersexuality in Placental Mammals 1995, Cambridge University Press, New York.
162. Josso N., Rey R., Gonzalès J. Sexual differentiation. Endotext.com/Pediatric Endocrinology, Chapter 7 2003, M.I. New (Ed.).
163. Lee M.M., Donahoe P.K. Müllerian inhibiting substance: a gonadal hormone with multiple functions. Endocrine Rev. 2003, 14:152-164.
164. Hayashi A., Donahoe P.K., Budzik G.P., Trelstad R.L. Periductal and matrix glycosaminoglycans in rat Müllerian duct development and regression. Dev. Biol. 1982, 92:16-26.
165. Roberts L.M., Visser J.A., Ingraham H.A. Involvement of a matrix metalloproteinase in MIS-induced cell death during urogenital development. Development 2002, 129:1487-1496.
166. Trelstad R.L., Hayashi A., Hayashi K., Donahoe P.K. The epithelial-mesenchymal interface of the male rate Müllerian duct: loss of basement membrane integrity and ductal regression. Dev. Biol. 1982, 92:27-40.
167. Ikawa H., Trelstad R.L., Hutson J.M., Manganaro T.F., Donahoe P.K. Changing patterns of fibronectin, laminin, type IV collagen, and a basement membrane proteoglycan during rat Müllerian duct regression. Dev. Biol. 1984, 102:260-263.
168. Paranko J., Pelliniemi L.J., Foidart J.M. Epithelio-mesenchymal interface and fibronectin in the differentiation of the rat mesonephric and paramesonephric ducts. Differentiation 1984, 27:196-204.
169. Roberts L.M., Hirokawa Y., Nachtigal M.W., Ingraham H.A. Paracrine-mediated apoptosis in reproductive tract development. Dev. Biol. 1999, 208:110-122.
170. George F.W., Peterson K.G. 5 alpha-dihydrotestosterone formation is necessary for embryogenesis of the rat prostate. Endocrinology 1988, 22:1159-1164.
171. Gottlieb B., Beitel L.K., Wu J.H., Trifiro M. The androgen receptor gene mutations database (ARDB): 2004 update. Hum. Mutat. 2004, 23:527-533.
172. Cooke P.S., Young P., Cunha G.R. Androgen receptor expression in developing male reproductive organs. Endocrinology 1991, 128:2867-2873.
173. Gupta C. The role of epidermal growth factor receptor (EGFR) in male reproductive tract differentiation: stimulation of EGFR expression and inhibition of Wolffian duct differentiation with anti-EGFR antibody. Endocrinology 1996, 137:905-910.
174. Gupta C., Bentlejewski C.A. Role of prostaglandins in the testosterone-dependent wolffian duct differentiation of the fetal mouse. Biol. Reprod. 1992, 47:1151-1160.
175. Cate R.L., Mattaliano R.J., Hession C., Tizard R., Farber N.M., Cheung A., Ninfa E.G., Frey A.Z., Gash D.J., Chow E.P., Fisher R.A., Bertonis J.M., Torres G., Wallner B.P., Ramachandran K.L., Ragin R.C., Manganaro T.F., MacLaughlin D.T., Donahoe P.K. Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells. Cell 1986, 45:685-698.
176. Pepinsky R.B., Sinclair L.K., Chow E.P., Mattaliano R.J., Manganaro T.F., Donahoe P.K., Cate R.L. Proteolytic processing of Müllerian inhibiting substance produces a transforming growth factor-beta-like fragment. J. Biol. Chem. 1988, 263:18961-18964.
177. Nachtigal M.W., Ingraham H.A. Bioactivation of Müllerian inhibiting substance during gonadal development by a kex2/subtilisin-like endoprotease. Proc. Natl. Acad. Sci. U S A 1996, 93:7711-7716.
178. Baarends W.M., van Helmond M.J., Post M., van der Schoot P.J., Hoogerbrugge J.W., de Winter J.P., Uilenbroek J.T., Karels B., Wilming L.G., Meijers J.H., Themmen A.P.N., Grootegoed J.A. A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the müllerian duct. Development 1994, 120:189-197.
179. di Clemente N., Wilson C., Faure E., Boussin L., Carmillo P., Tizard R., Picard J.Y., Vigier B., Josso N., Cate R. Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone.
180. Kobayashi A., Behringer R.R. Developmental genetics of the female reproductive tract. Nat. Rev. Genet. 2003, 4:969-980.
181. Kmita M., Deboule D. Organizing axes in time and space; 25 years of collinear tinkering. Science 2003, 301:331-333.
182. Daftary G.S., Taylor H.S. Implantation in the human: the role of HOX genes. Semin. Reprod. Med. 2000, 18:311-320.
183. Podlasek C.A., Seo R.M., Clemens J.Q., Ma L., Maas R.L., Bushman W. Hoxa-10 deficient male mice exhibit abnormal development of the accessory sex organs. Dev. Dyn. 1999, 214:1-12.
184. Benson G.V., Lim H., Paria B.C., Satokata I., Dey S.K., Maas R. Mechanisms of femalea infertility in Hoxa-10 mutant mice: uterine homesis versus loss of maternal Hoxa-10 expression. Development 1996, 122:2687-2696.
185. Akbas G.E., Song J., Taylor H.S. A HOXA10 estrogen response element (ERE) is differentially regulated by 17 beta-estradiol and diethylstilbestrol (DES). J. Mol. Biol. 2004, 340:1013-1023.
186. Block K., Kardana A., Igarashi P., Taylor H.S. In utero diethylstilbestrol (DES) exposure alters Hox gene expression in the developing müllerian system. FASEB J. 2000, 14:1101-1108.
187. Gendron R.L., Paradis H., Hsieh-Li H.M., Lee D.W., Potter S.S., Markoff E. Abnormal uterine stromal and glandular function associated with maternal reproductive defects in Hoxa-11 null mice. Biol. Reprod. 1997, 56:1097-1105.
188. Simpson J.L. Genetics of the female reproductive tracts. Am. J. Med. Genet. 1999, 89:224-239.
189. Mortlock D.P., Innis J.W. Mutation of HOXA13 in hand-foot-genital syndrome. Nat. Genet. 1997, 15:179-180.
190. Utsch B., Becker K., Brock D., Lentze M.J., Bidlingmaier F., Ludwig M. A novel stable polyalanine [poly(A)] expansion in the HOXA13 gene associated with hand-foot-genital syndrome: proper function of poly(A)-harbouring transcription factors depends on a critical repeat length?. Hum. Genet. 2002, 110:488-494.
191. Johnson K.R., Sweet H., Donahue L., Ward-Bailey P., Bronson R., Davidson M. A new spontaneous mouse mutation of Hoxd13 with a polyalanine expansion and phenotype similar to human synpolydactyly. Hum. Mol. Genet. 1998, 7:1033-1038.
192. Mortlock D.P., Post L.C., Innis J.W. The molecular basis of hypodactyly (Hd); a deletion in Hoxa13 leads to arrest of digital arch formation. Nat. Genet. 1996, 13:284-289.
193. Warot X., Fromental-Ramain C., Fraulob V., Chambon P., Dolle P. Gene dosage-dependent effects of the Hoxa-13 and Hoxd-13 mutations on morphogenesis of the terminal parts of the digestive and urogenital tracts. Development 1997, 124:4781-4791.
194. Bouchard M., Pfeffer P., Busslinger M. Functional equivalence of the transcription factors Pax2 and Pax5 in mouse development. Development 2000, 127:3703-3713.
195. Kuschert S., Rowitch D.H., Haenig B., McMahon A.P., Kispert A. Characterization of Pax-2 regulatory sequences that direct transgene expression in the Wolffian duct and its derivatives. Dev. Biol. 2001, 229:128-140.
196. Patel S.R., Dressler G.R. Expression of Pax2 in the intermediate mesoderm is regulated by YY1. Dev. Biol. 2004, 267:505-516.
197. Dressler G.R., Douglass E.C. Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor. Proc. Natl. Acad. Sci. U S A 1992, 89:1179-1183.
198. Torres M., Gomez-Pardo E., Dressler G.R., Gruss P. Pax-2 controls multiple steps of urogenital development. Development 1995, 121:4057-4065.
199. Bouchard M., Souabni A., Mandler M., Neubüser A., Buslsinger M. Nephric lineage specification by Pax2 and Pax8. Genes Dev. 2002, 16:2958-2970.
200. Pellegrini M., Pantano S., Lucchini F., Fumi M., Forabosco A. Emx2 developmental expression in the primordia of the reproductive and excretory systems. Anat. Embryol. (Berl). 1997, 196:427-433.
201. Barnes J.D., Crosby J.L., Jones C.M., Wright C.V., Hogan B.L. Embryonic expression of Lim-1, the mouse homolog of Xenopus Xlim-1, suggests a role in lateral mesoderm differentiation and neurogenesis. Dev. Biol. 1994, 161:168-178.
202. Kobayashi A., Shawlot W., Kania A., Behringer R.R. Requirement of Lim1 for female reproductive tract development. Development 2004, 131:539-549.
203. Tsang T.E., Shawlot W., Kinder S.J., Kobayashi A., Kwan K.M., Schughart K., Kania A., Jessell T.M., Behringer R.R., Tam P.P. Lim1 activity is required for intermediate mesoderm differentiation in the mouse embryo. Dev. Biol. 2000, 223:77-90.
204. di Clemente N., Josso N., Gouédard L., Belville C. Components of the anti-Müllerian hormone signaling pathway in gonads. Mol. Cell. Endocrinol. 2003, 211:9-14.
205. Imbeaud S., Belville C., Messika-Zeitoun L., Rey R., di Clemente N., Josso N., Picard J.Y. A 27 base-pair deletion of the anti-müllerian type II receptor gene is the most common cause of the persistent müllerian duct syndrome. Hum. Mol. Genet. 1996, 5:1269-1277.
206. Mishina Y., Rey R., Finegold M.J., Matzuk M.M., Josso N., Cate R.L., Behringer R.R. Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev. 1996, 10:2577-2587.
207. Jamin S.P., Arango N.A., Mishina Y., Hanks M.C., Behringer R.R. Requirement of Bmpr1a for Müllerian duct regression during male sexual development. Nat. Genet. 2002, 32:408-410.
208. Gouedard L., Chen Y.G., Thevenet L., Racine C., Borie S., Lamarre I., Josso N., Massague J., di Clemente N. Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Müllerian hormone and its type II receptor. J. Biol. Chem. 2000, 275:27973-27978.
209. Visser J.A., Olaso R., Verhoef-Post M., Dramer P., Themmen A.P. The serine/threonine kinase transmembrane receptor ALK2 mediates Mulerian inhibiting substance binding. Mol. Endocrinol. 2001, 15:936-945.
210. Mishina Y., Crombie R., Bradley A., Behringer R.R. Multiple roles for activin-like kinase-2 signaling during mouse embryogenesis. Dev. Biol. 1999, 213:314-326.
211. Heikkila M., Peltoketo H., Vainio S. Wnts and the female reproductive system. J. Exptl. Zool. 2001, 290:616-623.
212. Parr B.A., McMahon A.P. Sexually dimorphic development of the mammalian reproductive tract requires Wnt-7a. Nature 1998, 395:707-710.
213. Parker K.L. Sexual differentiation. Textbook of Endocrine Physiology 2004, 167-185. Oxford University Press, London. J.E. Griffin, S.R. Ojeda (Eds.).